Journal for ImmunoTherapy of Cancer (Nov 2023)
446 The administration of JAK and TYK2 inhibitor successfully ameliorated the severity of T cell transfer-induced colitis in mice
Abstract
No abstracts available.
Journal for ImmunoTherapy of Cancer (Nov 2023)